AIM · AIM ImmunoTech Inc.

AIM ImmunoTech Inc. executed a warrant exercise inducement transaction to accelerate cash inflow by incentivizing holders of existing Class A-F warrants to exercise early at a reduced price of $0.48 per share, generating approximately $3.6 million in gross proceeds upon closing on May 8, 2026. In exchange, the company issued new Class H Inducement Warrants for up to 14,903,840 shares at $0.60 per share, exercisable only after the Stockholder Approval Date for a five-year term. This structure allows the company to secure immediate liquidity while deferring potential future dilution until stockholder approval and exercise occurs at a higher price. Ladenburg Thalmann & Co. Inc., as placement agent, earned standard fees totaling about $361,000 and received Placement Agent Warrants for 894,230 shares—equivalent to 6% of the exercised shares—with terms mirroring the Inducement Warrants including a $0.60 exercise price and piggyback registration rights. All warrants and underlying shares were issued exempt from Securities Act registration under Section 4(a)(2), restricting resale absent registration or exemption.